Schematic overview of neurodegenerative pathophysiology and esculetin intervention.Top: activated microglia and astrocytes release pro-inflammatory cytokines (TNF-, IL-1, IL-6) in the central nervous system.Middle: the glia-mitochondria-cytokine axis drives neurodegeneration through ROS-mediated oxidative stress and mitochondrial dysfunction (red arrows indicate pathological progression).Bottom left (Alzheimers disease): amyloid-beta plaques and tau tangles characterize AD pathology
However, natural GLP-1 is quickly broken down by dipeptidyl peptidase 4 (DPP4) after it is released [2]
An overactive cytokine response is associated with chronic inflammatory conditions and was a notable factor in severe COVID-19 cases, where studies found that many seriously ill patients had significantly depleted glutathione stores
Since the first semaglutide drug was approved in 2005, patients and manufacturers have seen many changes: shortages, compounding, and more than a thousand lawsuits from patients who experienced severe side effects under these drugs, including stomach paralysis, bowel obstruction, and vision loss
In some cases, patients experience headaches or dizziness
It can lead to feeling fuller for longer, reducing calorie intake, and promoting weight loss